For many people living with hepatitis B, the main worry is cirrhosis. Yet hepatitis B is unusual among liver diseases because it can lead to liver cancer even when the liver has not become cirrhotic. Understanding this helps explain why some hepatitis B patients are advised to have regular checks and others are not.
The Short Answer
Yes. Hepatitis B virus (HBV) can contribute to liver cancer directly, not only by causing scarring. A substantial share of HBV-related liver cancers occur in people without cirrhosis. This does not mean everyone with hepatitis B will develop cancer. Most will not, and risk varies widely between individuals.
Why HBV Differs From Other Causes
HBV can integrate its genetic material into the DNA of liver cells. Together with long-term inflammation and ongoing cell turnover, this can promote cancerous changes. In many other liver diseases, cancer risk rises mainly once significant scarring has developed. This is one reason why hepatitis B needs its own approach, and why it should be kept separate from fatty liver, which is covered in fatty liver and liver cancer without cirrhosis.
Factors That Raise Risk in Hepatitis B
| Factor | Why It Matters |
| Older age | Longer duration of infection |
| Male sex | Higher observed risk in studies |
| Family history of liver cancer | Shared genetic and environmental factors |
| High HBV DNA level | More active viral replication |
| Persistent liver inflammation | Ongoing cell injury and regeneration |
| Cirrhosis | The strongest single risk factor |
| Coinfection with hepatitis C or hepatitis D | Added liver injury |
| Heavy alcohol use, diabetes, obesity | Additional liver stress |
| Aflatoxin exposure | A known contributor in some regions |
| Certain viral genotypes | Associated with higher risk in some studies |
Who Is Usually Offered Surveillance?
Eligibility is not identical for every hepatitis B patient, and it depends on the guideline and on your individual profile. In general:
- People with cirrhosis: surveillance is recommended
- People without cirrhosis but at higher risk: many guidelines suggest surveillance for Asian men from around age 40 and Asian women from around age 50, or earlier with a family history of liver cancer
- Risk scores: some guidelines use scores such as PAGE-B, which combine age, sex and platelet count, to identify higher-risk patients
- Lower-risk patients: may not need routine surveillance, though they are still monitored for their hepatitis B
Because criteria differ, ask your hepatologist whether you meet surveillance criteria rather than assuming either way.
What Surveillance Involves
Surveillance generally means a liver ultrasound, often with an AFP blood test, about every 6 months. If an abnormality appears, CT or MRI is used to investigate further. For why AFP alone is not enough, see is an AFP blood test enough to detect liver cancer?
Antiviral Treatment and Risk
Antiviral treatment for hepatitis B suppresses the virus and can reduce the risk of liver cancer, as well as slow or limit scarring. It does not remove the risk entirely, especially in people who are older or already have significant fibrosis. This is why many patients on effective treatment continue to have surveillance if they meet the criteria.
Practical Steps for People With Hepatitis B
- Know your status: keep records of HBV DNA, liver tests and imaging
- Attend monitoring visits even when you feel well
- Ask whether you meet surveillance criteria for your age, sex and family history
- Discuss antiviral treatment if you have not already
- Limit alcohol and avoid smoking
- Encourage family members to be tested and vaccinated, since hepatitis B can spread within families
Hepatitis B in Malaysia
Hepatitis B remains a significant cause of chronic liver disease in Malaysia, particularly among adults born before national infant vaccination began in the late 1980s. For the broader picture of who needs checks and how often, see liver cancer risk and screening in Malaysia. For people who have already developed cirrhosis, our liver cirrhosis page explains standard care.
Frequently Asked Questions
Does everyone with hepatitis B need regular liver cancer checks?
No. Eligibility depends on factors such as cirrhosis, age, sex and family history. Your hepatologist will tell you whether you meet surveillance criteria.
Can I get liver cancer from hepatitis B if my liver is not scarred?
Yes. HBV can contribute to cancer even without cirrhosis, which is why some non-cirrhotic patients with higher risk are still offered surveillance.
Does antiviral treatment make me safe from liver cancer?
It lowers risk but does not remove it. You may still need regular surveillance if you are in a higher-risk group.
How often is surveillance done?
Generally an ultrasound, often with AFP, about every 6 months. Your doctor will set the schedule that fits your situation.
Should my family be tested?
Often yes. Hepatitis B can run in families, and relatives can be tested, vaccinated if not immune, and monitored if infected.
This article is for general education and does not replace medical advice.